The Extracellular Vesicles Based Liquid Biopsy Market is a cornerstone of the future of precision medicine. With a projected value of USD 539.41 Million by 2032 and a robust CAGR of 21.3%, the industry is moving from the research phase into mainstream clinical application. While challenges regarding standardization and regulatory pathways remain, the integration of AI-driven analysis ... https://www.databridgemarketresearch.com/reports/global-extracellular-vesicles-based-liquid-biopsy-market